Camzyos®▼(mavacamten) recommended for use on the NHS as an add-on treatment option for adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM)Mavacamten has been recommended by the National Institute for Health and Care Excellence (NICE), as an add-on to individually optimised standard care, for t.
On August 15, 2023, the U.S. Food and Drug Administration (“FDA”) released final guidance on informed consent for clinical investigations (“Final Guidance”). This update follows FDA’s.
federalregister.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from federalregister.gov Daily Mail and Mail on Sunday newspapers.
Almost a year to the day after the Build America Buy America Act (BABA) became law, the federal Office of Management and Budget (OMB) has published its “Final Guidance for Grants and.
Revised guidance takes effect on October 22, 2023 and will be supplemented by forthcoming memorandum - On August 23, the Office of Management and Budget (“OMB”) published.